The University of Chicago Header Logo

Connection

Jeremy Segal to Triazines

Back to Details
This is a "connection" page, showing publications Jeremy Segal has written about Triazines.
Jeremy Segal
Connection Strength
0.172
Triazines
  1. Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib. Br J Haematol. 2020 07; 190(1):e48-e51.
    View in: PubMed
    Score: 0.172
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.